Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Sanofi SA    SNY

Delayed Quote. Delayed  - 09/27 10:02:03 pm
38.15 USD   +0.29%
09/27 SANOFI : BARDA Grants $ 43.2 million USD to Sanofi Pasteur for Zika?
09/27 FDA GRANTS PRIO : REGN), Sanofi SA (NYSE:SNY)
09/27 SANOFI : (SNY) Receives $43.2M BARDA Grant for Zika Vaccine Developm..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi SA
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

It operates through the following segments: Pharmaceuticals, Human Vaccines, and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing of vaccines.

The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for a wide variety of animal species.The company was founded on April 28, 1994 and is headquartered in Paris, France.

Number of employees : 115 631 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Pharmaceuticals36,62882.1%32,88886.3% -10.21%
Vaccines5,25111.8%5,23513.7% -0.31%
Animal Health2,7436.1%---
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
Other Countries15,13333.9%13,05634.2% -13.73%
United States14,98333.6%13,51535.5% -9.79%
Europe10,48123.5%8,40222% -19.83%
France3,2697.3%2,4816.5% -24.1%
North America755.811.7%667.711.8% -11.66%
Managers
NameAgeSinceTitle
Olivier Brandicourt MD, PhD602015Chief Executive Officer & Director
Serge Weinberg652009Chairman
Jérôme Contamine592009Chief Financial Officer & EVP-Finance
Elias E. Zerhouni, MD652011President-Global Research & Development
Yong-Jun Liu MD, PhD-2016Head-Global Research & Development
Ameet Nathwani MD, MBA-2016Group Chief Medical Officer & Executive VP
Robert Castaigne, PhD702000Independent Director
Jean-René Fourtou772004Independent Director
Claudie Haigneré MD, PhD592008Independent Director
Uwe Bicker MD, PhD712008Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 1,287,105,713 1,154,017,657 89.7% 100,000 0.0% 89.7%
Shareholders
NameEquities%
Dodge & Cox 55,155,913 2.14%
Barrow, Hanley, Mewhinney & Strauss LLC 28,122,279 1.09%
Franklin Advisers, Inc. 20,829,292 0.81%
Fisher Asset Management LLC 13,638,183 0.53%
Hotchkis & Wiley Capital Management LLC 11,432,112 0.44%
Invesco Advisers, Inc. 8,743,817 0.34%
Fidelity Management & Research Co. 7,510,701 0.29%
Boston Partners Global Investors, Inc. 7,402,009 0.29%
Harris Associates LP 5,572,075 0.22%
Berkshire Hathaway, Inc. (Investment Management) 3,905,875 0.15%
Holdings
NameEquities%Valuation
Regeneron Pharmaceuticals Inc (REGN) 23,418,39622.7%9,192,891,350 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%913,594,193 USD
Alnylam Pharmaceuticals, Inc. (ALNY) 10,256,63312.0%716,425,815 USD
Sanofi (SAN) 3,956,7080.31%304,376,529 USD
Zentiva SA (ROSCD) 312,341,64974.9%153,569,019 USD
Myokardia Inc (MYOK) 3,218,89911.9%70,429,510 USD
Voyager Therapeutics Inc (VYGR) 2,477,9419.26%30,156,542 USD
Regulus Therapeutics Inc (RGLS) 5,053,7799.57%16,020,479 USD
Proteome Sciences plc (PRM) 38,0000.017%7,217 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
SANOFI SA-10.55%97 974
JOHNSON & JOHNSON16.06%322 232
ROCHE HOLDING LTD.-12.41%215 081
NOVARTIS AG-10.14%211 231
PFIZER INC.4.80%204 049
MERCK & CO., INC.18.46%171 858
GLAXOSMITHKLINE PLC19.26%103 357
SANOFI-13.56%97 974
ALLERGAN PLC-23.40%94 506
BRISTOL-MYERS SQUIBB C..-18.97%92 699
NOVO NORDISK A/S-25.93%89 965
ELI LILLY AND CO-4.01%87 778
ASTRAZENECA PLC9.56%83 672
BAYER AG-23.33%82 947
ABBOTT LABORATORIES-5.74%61 269
SHIRE PLC9.47%59 910
TAKEDA PHARMACEUTICAL ..-18.40%37 934
ASTELLAS PHARMA INC-6.43%33 941
MYLAN NV-23.60%22 028
CHUGAI PHARMACEUTICAL ..-11.75%20 281
EISAI CO., LTD-18.27%18 882
Sector Pharmaceuticals - NEC
Sanofi SA : Connections
Bordeaux University Foundation
Académie Nationale de Médecine
Maremma SASU
L'Oréal Corporate Foundation
Financières SASA
MedImmune LLC
Piasa SA
Fondation C.Génial
Académie des Sciences et Technologies
Madrigall SA
Institute of Medicine
National Committee on United States-China Relations, Inc.
The Children's Aid Society, Inc.
Council on Foreign Relations, Inc.
Fondation Lacoste
Sanofi-Aventis Europe SAS
Academie des Sports
Sanofi-Aventis Participations SA
Piasa Holding SAS
National Academy of Engineering
The Johns Hopkins University
Sanofi-Aventis U.S. LLC
International Federation of Pharmaceutical Manufacturers A
Financière Piasa SAS
Pharmaceutical Research & Manufacturers of America
Sanofi Pasteur Holding SA
Sanofi Pasteur Holding & Merial Ltd.
Fondation de France
Pres héSam
Aventis Foundation
Fondation pour l’Université de Lyon
Weinberg Capital Partners SAS
Académie des Technologies
King Abdullah University of Science & Technology
Academie de l'air et de l'espace
Warp Drive Bio LLC
Philipps University of Marburg
Research!America
Ruprecht-Karls-Universität Heidelberg
Company contact information
Sanofi
54, rue La Boétie
Paris, Ile-de-France 75008

Phone : +33.1.53.77.40.00
Fax : +33.1.53.77.44.63
Web : www.sanofi.com
© 2016 People , Fundamentals and Ownership